Gene · 4841
Papers2,010
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,010
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Tale of DJ-1 (PARK7): A Swiss Army Knife in Biomedical and Psychological Research. | Int J Mol Sci | 2023 | 37108572 | PubTator, text mining | PubMed |
| High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma. | J Exp Clin Cancer Res | 2023 | 37095531 | PubTator, text mining | PubMed |
| Multi-omic profiling reveals an RNA processing rheostat that predisposes to prostate cancer. | EMBO Mol Med | 2023 | 37093546 | PubTator, text mining | PubMed |
| Biomolecular Liquid-Liquid Phase Separation for Biotechnology. | BioTech (Basel) | 2023 | 37092470 | PubTator, text mining | PubMed |
| African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A. | Cancer Res Commun | 2023 | 37082578 | PubTator, text mining | PubMed |
| Senotherapeutics: An emerging approach to the treatment of viral infectious diseases in the elderly. | Front Cell Infect Microbiol | 2023 | 37065192 | PubTator, text mining | PubMed |
| Estrogen associates with female predominance in Xp11.2 translocation renal cell carcinoma. | Sci Rep | 2023 | 37061606 | PubTator, text mining | PubMed |
| Primary role of type I interferons for the induction of functionally optimal antigen-specific CD8+ T cells in HIV infection. | EBioMedicine | 2023 | 37058769 | PubTator, text mining | PubMed |
| Integrated systems immunology approach identifies impaired effector T cell memory responses as a feature of progression to severe dengue fever. | J Biomed Sci | 2023 | 37055751 | PubTator, text mining | PubMed |
| R-Loops at Chromosome Ends: From Formation, Regulation, and Cellular Consequence. | Cancers (Basel) | 2023 | 37046839 | PubTator, text mining | PubMed |
| PTBP2-Mediated Alternative Splicing of IRF9 Controls Tumor-Associated Monocyte/Macrophage Chemotaxis and Repolarization in Neuroblastoma Progression. | Research (Wash D C) | 2023 | 37040518 | PubTator, text mining | PubMed |
| Ultra-conserved RNA: a novel biological tool with diagnostic and therapeutic potential. | Discov Oncol | 2023 | 37036543 | PubTator, text mining | PubMed |
| The KMT2A recombinome of acute leukemias in 2023. | Leukemia | 2023 | 37019990 | PubTator, text mining | PubMed |
| Expression of the primate-specific LINC00473 RNA in mouse neurons promotes excitability and CREB-regulated transcription. | J Biol Chem | 2023 | 37019214 | PubTator, text mining | PubMed |
| A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer. | Acta Pharmacol Sin | 2023 | 37012494 | PubTator, text mining | PubMed |
| M6A-Related Long Non-Coding RNA Displays Utility in Predicting Prognosis, Portraying the Tumor Immune Microenvironment and Guiding Immunotherapy in Pancreatic Ductal Adenocarcinoma. | Vaccines (Basel) | 2023 | 36992083 | PubTator, text mining | PubMed |
| Detection of Nα-terminally formylated native proteins by a pan-N-formyl methionine-specific antibody. | J Biol Chem | 2023 | 36990220 | PubTator, text mining | PubMed |
| Circadian Oscillations in Skin and Their Interconnection with the Cycle of Life. | Int J Mol Sci | 2023 | 36982706 | PubTator, text mining | PubMed |
| A Liquid-Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients. | Int J Mol Sci | 2023 | 36982591 | PubTator, text mining | PubMed |
| Alternative mRNA Splicing and Promising Therapies in Cancer. | Biomolecules | 2023 | 36979496 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4841/papers?page=13